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Abstract  
 
The intracellular transport of organelles, proteins, lipids and RNA along the 
axon is essential for neuronal function and survival. This process, called 
axonal transport, is mediated by two classes of ATP-dependent motors, 
kinesins and cytoplasmic dynein, which carry their cargoes along microtubule 
tracks. Protein kinases regulate axonal transport through direct 
phosphorylation of motors, adapter proteins and cargoes, and indirectly, 
through modification of the microtubule network. The misregulation of axonal 
transport by protein kinases has been implicated in the pathogenesis of 
several nervous system disorders. Here, we review the role of protein kinases 
acting directly on axonal transport and discuss how their deregulation affects 
neuronal function, paving the way for the exploitation of these enzymes as 
novel drug targets. 
 
Axonal transport in neuronal function and survival 
 
Neurons are highly polarized cells, with axons that can reach over a meter 
away from the cell body in large mammals. This unique morphology makes 
neurons particularly dependent on active intracellular transport along the 
axon. Axonal transport is essential for the delivery of newly synthesized 
proteins, lipids and RNA, as well as organelles, to growth cones and 
synapses. It is also required for the removal of damaged cellular components 
and organelles for degradation and recycling. Furthermore, axonal transport 
has been shown to play a key role in long-distance communication between 
the distal region of the axon and the cell body, including neurotrophic and 
injury response signaling [1-3] and the regulation of axonal length [4]. 
Congruent with the crucial role of axonal transport in neuronal homeostasis, 
disruptions in axonal transport have been linked to neuronal dysfunction and 
degeneration [5, 6]. 
 
The complex spatial and temporal regulation of axonal transport is essential 
for controlled delivery of selected cargoes (see Glossary) to specific 
neuronal domains. Whilst a complete understanding of axonal transport 
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regulation is still lacking, it has been known for some time that 
phosphorylation plays an important role in this process [7, 8]. However, 
deciphering which protein kinases are responsible for axonal transport 
modulation has been difficult, as kinase cascades display considerable 
crosstalk and play multiple roles in neuronal homeostasis [9-12]. Recently, 
significant progress has been made in dissecting out the role of individual 
kinases in this process and identifying their molecular targets. 
 
Protein kinases are known to regulate axonal transport through direct 
phosphorylation of motors, adapter proteins and cargoes, and indirectly, 
through modification of the microtubule network. The diversity of protein 
kinases implicated in axonal transport regulation most likely underlies the 
complexity of this process and explains why transport characteristics are 
distinct between different types of neurons (for example, axonal transport is 
slower in sensory versus motor neurons) [13] and cargoes (for example, 
mitochondria move bidirectionally with frequent pauses, whilst signaling 
endosomes undergo sustained retrograde transport) [13, 14]. 
 
Here, we review the role of protein kinases that have been implicated in the 
direct regulation of axonal transport and discuss how kinase deregulation can 
affect neuronal function. 
 
The axonal transport machinery 
 
Axonal transport can be classified based on the speed at which cargoes 
move. Vesicles, organelles and RNA are transported by fast axonal transport 
at a speed of 50-200 mm per day (0.5-3 μm/s), whilst cytoskeletal 
components (such as neurofilaments and tubulin) and some soluble proteins 
are transported by slow axonal transport and move at rates of 0.1–3 mm per 
day [6].  
 
Both types of transport are mediated by two classes of ATP-dependent 
motors - kinesin and cytoplasmic dynein - which carry their cargoes along 
microtubule tracks running the length of the axon [15]. Kinesin and dynein are 
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assisted by adapter proteins, which link the motors to their cargoes and 
regulate the activity of the motors. Microtubules impart an intrinsic polarity to 
neurons, with their “plus” ends located at the axon tips and their “minus” ends 
within the cell body (Key Figure). This polarity confers directionality to axonal 
transport. 
 
Anterograde axonal transport  
Anterograde axonal transport refers to the movement of cargoes from the cell 
body towards the axon tips and is mediated by kinesin motor proteins. 
 
Kinesin-1 motors are responsible for the fast anterograde axonal transport of 
most vesicles, organelles, proteins and RNA particles and the slow axonal 
transport of cytoskeletal proteins. Kinesin-1 family members are 
heterotetramers composed of two heavy chains (KIF5A-C) and two light 
chains (KLC1/2). KIFs comprise the motor domains and contain both ATP and 
microtubule binding motifs. KLCs interact with the tails of the KIFs and are 
thought to regulate cargo binding and motor activity [16] (see Box 1). 
 
Kinesin-2 and kinesin-3 motors are also important for axonal transport. 
Members of the kinesin-2 family (KIF3A/KIF3B/KAP3) mediate the transport of 
late endosome-lysosomes [17, 18], whilst kinesin-3 motors (KIF1A and 
KIF1Bβ) carry synaptic vesicle precursors and dense core vesicles [19, 20]. 
 
Retrograde axonal transport  
Retrograde axonal transport refers to the movement of cargoes from the axon 
tips to the cell body and is mediated by cytoplasmic dynein. Dynein is 
composed of two heavy chains and additional intermediate, light intermediate 
and light chains [15]. The heavy chain contains ATP and microtubule-binding 
motifs at its carboxy terminus, whilst the amino terminus interacts with the 
additional chains to form the cargo-binding domain. Dynein is found in a 
complex with dynactin [16], a multi-subunit cofactor that is essential for its 
function (see Box 1), and other adapter proteins, such as lissencephaly-1 
(Lis1) and huntingtin (htt) [6]. 
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Kinases implicated in the regulation of axonal transport 
 
Protein kinases regulate axonal transport through direct phosphorylation of 
motors, adapters and cargoes (summarized in Table 1). Importantly, protein 
kinases also phosphorylate several factors involved in the regulation of 
microtubule stability, as discussed in detail elsewhere [21]. 
 
Glycogen synthase kinase-3 beta (GSK3β) 
GSK3β was originally identified as a regulator of glycogen metabolism [22], 
but has since been shown to be a multifunctional kinase with numerous roles 
in the nervous system [9]. In both invertebrate and rodent models, GSK3β 
acts as a negative regulator of anterograde and retrograde axonal transport 
(Figure 1 and 2) [23-28]. In Drosophila, overexpression of GSK3 inhibits the 
axonal transport of mitochondria [24, 25], amyloid precursor protein (APP)-
containing vesicles [27] and lipid droplets in larval segmental nerves [27]. 
There are conflicting views over whether GSK3 also inhibits the axonal 
transport of synaptic vesicles in these nerves [25, 27]. Stimulation of GSK3β 
by pathological proteins, such as presenilin 1 and amyloid beta (Aβ) (see 
Relevance to CNS function and disease section) also inhibits bidirectional 
axonal transport in mammalian neurons [29, 30] (Table 1).  
 
Pharmacological inhibition of GSK3β in hippocampal and sensory (DRG) 
neurons has been shown to stimulate the axonal transport of BDNF-
containing secretory vesicles, mitochondria and acidic organelles [24, 28]. 
Similar results are also seen in Drosophila larval segmental nerves carrying 
loss-of-function mutations in GSK3 [27]. However, in squid axoplasm, 
inhibition of GSK3β did not alter the axonal transport of membrane-bound 
organelles [26], indicating that this regulatory mechanism is not conserved 
between all species.  
 
GSK3β regulates axonal transport through direct phosphorylation of motors 
and their adapters. In squid axoplasm, GSK3β was shown to phosphorylate 
KLC2, stimulating its release from cargoes, without influencing the 
microtubule binding or ATPase activity of the motor [26]. However, optical trap 
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experiments in Drosophila indicate that GSK3β may instead act to reduce the 
number of active kinesins working at any one time, rather than the total 
number of motors bound to the cargo [27]. These contrasting results may 
represent differences in the regulation of axonal transport between species. 
GSK3β directly phosphorylates dynein intermediate chain 1B (DIC1B) and 2C 
(DIC2C), leading to inhibition of the retrograde axonal transport of acidic 
organelles [28]. GSK3β-mediated phosphorylation of DIC1B was shown to 
reduce its interaction with Ndel1 and Lis1, which enhance dynein force 
production [31]. 
 
GSK3β has also been shown to regulate axonal transport through 
phosphorylation of motor adapter proteins. Collapsin response mediator 
protein-2 (CRMP-2) acts as a linker between kinesin-1 and specific cargoes 
such as tubulin heterodimers and TrkB-containing endosomes [32]. GSK3β-
mediated phosphorylation of CRMP-2 disrupts its association with KLC1 and 
is proposed to perturb the anterograde axonal transport of its cargoes [33] 
(Figure 1). However, this effect has yet to be demonstrated in live axonal 
transport assays. 
 
Finally, GSK3β has been found to have differential effects on slow axonal 
transport, depending on the type of cargo being transported. For example, 
GSK3β directly phosphorylates tau [34], increasing its affinity for kinesin-1 
and thereby accelerating its anterograde axonal transport [35]. By contrast, 
GSK3β-mediated phosphorylation of neurofilament heavy chain (NF-H) 
increases neurofilament bundling and reduces their anterograde axonal 
transport [36].  
 
Mitogen-activated protein kinases (MAPKs) 
MAPKs are serine/threonine protein kinases that coordinate cellular 
responses to diverse extracellular stimuli. In its simplest form, MAPK signaling 
can be considered as a cascade of three tiers of protein kinases: MAPK 
kinase kinases (ASK1, TAK1, RAF1, MLK, MEKK4), MAPK kinases (MEK1, 
MKK4/7 and MKK3/6) and MAPKs (ERKs, JNKs and p38 MAPKs). However, 
representing the MAPK cascade as three isolated pathways is an 
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 7 
oversimplification; the MAPK signaling network functionally interacts with 
many other pathways via shared scaffolding proteins, which target them to 
specific cellular locations [37]. In addition, there are several isoforms of each 
MAPK, each with distinct functions [37].  
 
ERK1/2. Extracellular-signal-regulated kinases 1 and 2 (ERK1/2, also known 
as p44/42 MAPK) are activated in response to mitogens and growth factors, 
including neurotrophins [38], and have been shown to play a key role in 
neuronal differentiation, plasticity and survival [39, 40]. ERK1/2 directly 
phosphorylate both kinesin-1 (Figure 1) and dynein (Figure 2) and thereby 
regulate their association with cargoes [41, 42]. In rodent cortical neurons, 
ERK1/2-mediated phosphorylation of DIC1B and DIC2C increases the 
association of dynein with TrkB/Rab7-positive signaling endosomes, leading 
to an increase in the number of signaling endosomes moving in the retrograde 
direction (Figure 2) [42]. Interestingly, phosphorylation of DIC1B and DIC2C 
by ERK1/2 does not alter the ability of dynein to bind to mitochondria in these 
neurons, suggesting that mitochondria utilize a different mechanism to recruit 
dynein [42]. By contrast, ERK1/2-induced phosphorylation of KLC1 at Ser460 
prevents binding of the motor to APP-labeled vesicles [41, 43], leading to a 
decrease in their anterograde transport frequency (Figure 1) [41]. ERK1/2-
mediated phosphorylation of KLC1, however, has no effect on the axonal 
transport of other cargoes, such as CRMP2 or the neurotrophin receptor 
scaffolding protein Kidins220/ARMS [41]. This suggests that ERK1/2 only 
mediate the fast retrograde axonal transport of specific cargoes. 
 
Interestingly, activated ERK1/2 are also cargoes of signaling endosomes and 
are transported to the cell body where they induce changes in neurotrophin-
dependent gene expression [44]. This raises the question of how the transport 
machinery is protected from spurious modification by transported kinases. 
Although the exact mechanism is currently unknown, it could be speculated 
that the interaction of ERK1/2 with vimentin, which prevents 
dephosphorylation and deactivation of the kinases [45], could also preclude 
ERK1/2 from phosphorylating the transport machinery en route.  
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ERK1/2 have also been shown to facilitate the slow anterograde axonal 
transport of neurofilaments [36]. ERK1/2 attenuate GSK3β-mediated bundling 
of neurofilaments, leading to an increase in their transported pool [36]. 
However, ERK1/2 activity has no effect on the slow axonal transport of tau, 
indicating this regulatory mechanism is also cargo-specific [46]. 
 
p38 MAPKs. p38 MAPKs are activated in response to pro-inflammatory 
cytokines, such as tumor necrosis factor α (TNFα) and interleukin (IL)-1β, and 
cellular stresses, such as hypoxic, genotoxic or oxidative stress [47]. There 
are four p38 MAPK isoforms: α, β, γ and δ. p38 MAPKα and β are considered 
to be the major isoforms expressed in the central nervous system [48]. 
 
p38 MAPK is a negative regulator of both fast and slow axonal transport. In 
squid axoplasm, p38 MAPKα directly phosphorylates KIF5C at 
Ser175/Ser176 and thereby inhibits the fast anterograde axonal transport of 
membrane-bound organelles (Table 1) [48]. In contrast, p38 MAPKβ inhibits 
both anterograde and retrograde axonal transport in this system [48]. p38 
MAPK-mediated inhibition of fast axonal transport has also been described for 
mitochondria in rodent hippocampal neurons [48, 49] and synaptic vesicles in 
Drosophila segmental nerves [50] (Figure 1 and 2), suggesting that this 
regulatory mechanism is conserved between species. However, the targets of 
this kinase in the mammalian transport machinery are presently unknown. 
 
Activation of p38 MAPK has also been shown to inhibit the slow anterograde 
axonal transport of neurofilaments [51]. p38 MAPKα phosphorylates the tail 
domains of neurofilament medium (NF-M) and NF-H chains and regulates 
their attachment to motor proteins [52]. In rat cortical neurons, increased 
phosphorylation of NF-M and NF-H slows their axonal transport and induces 
bundling, leading to large accumulations of neurofilaments in the cell body 
and proximal axons [53].  
 
JNKs. The c-Jun N-terminal kinases (JNKs) are encoded by three genes: 
JNK1 and 2 are expressed ubiquitously, while JNK3 is only expressed in 
neurons [11]. Similarly to p38 MAPK, JNKs are activated by cellular stress 
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and pro-inflammatory cytokines [54]. In addition to their physiological roles in 
neuronal development and synaptic plasticity, over-activation of JNKs has 
been implicated in several neurological disorders [11].  
 
JNKs regulate axonal transport via direct phosphorylation of motors, adapter 
proteins and cargoes. In squid axoplasm, JNK3 inhibits fast anterograde 
axonal transport via direct phosphorylation of KIF5C at Ser176, reducing 
kinesin-1 function and its ability to bind to microtubules [55, 56]. Activation of 
JNK also inhibits the axonal transport of synaptic vesicles and mitochondria in 
rodent hippocampal neurons (Figure 1 and 2) [57]. In these studies, JNK was 
found to directly phosphorylate KIF5B and induce its dissociation from 
microtubules [57]. The mechanism responsible for JNK-mediated inhibition of 
retrograde axonal transport remains unclear (Figure 2).  
 
JNK also regulates fast axonal transport via phosphorylation of JNK 
interacting protein 1 (JIP1). JIPs not only act as signaling platforms for JNKs 
[58], but also serve as adapter proteins for both dynein and kinesin [59, 60] 
(Figure 1 and 2). In rodent neurons, phosphorylation of JIP1 at Ser421 
stabilizes its interaction with kinesin-1 and promotes the anterograde axonal 
transport of APP, whilst expression of a non-phosphorylatable JIP1 mutant 
favors retrograde axonal transport [60]. Thus, JNK-mediated phosphorylation 
of JIP1 could act as a molecular switch between retrograde and anterograde 
axonal transport [60]. 
 
Similarly to ERK1/2, JNK is also a signaling endosome cargo and its 
retrograde axonal transport is essential for the response to axonal injury [61]. 
Given the inhibitory effect of JNK on retrograde axonal transport, there must 
be additional regulatory mechanisms in place to allow its processive transport 
along the axon. It has been suggested that JIP-1 modulates JNK signaling 
during transport via association with protein phosphatases [62]. For example, 
JIP1 has been shown to bind the dual-specificity phosphatase MAPK 
phosphatase 7 (MKP7), which dephosphorylates and inactivates JNK [63]. 
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Finally, JNK1 has been shown to negatively regulate slow anterograde axonal 
transport. In chick sensory neurons, JNK1 was found to directly phosphorylate 
neurofilaments, leading to inhibition of their slow axonal transport [64].  
 
Cyclin Dependent Kinase 5 (Cdk5) 
Cdk5 was first discovered based on its sequence homology to other cyclin-
dependent kinases such as Cdc2 and Cdk2 [65, 66]. However, unlike other 
cyclin-dependent kinases, Cdk5 does not play a direct role in cell cycle 
control. Instead, Cdk5 regulates several processes in the nervous system, 
including neurite outgrowth, synaptic activity and neuronal migration [12], and 
its deregulation has been linked to neurodegeneration [67, 68]. 
 
The role of Cdk5 in the regulation of axonal transport is controversial, with 
dispute over whether the kinase regulates axonal transport under normal 
conditions or only in response to cellular stress. In squid axoplasm and C. 
elegans motor neurons, inhibition of Cdk5 was reported to disrupt the 
anterograde axonal transport of membrane-bound organelles [69, 70] and the 
retrograde axonal transport of synaptic vesicles [71]. Similarly, expression of 
kinase-dead Cdk5 led to inhibition of both anterograde and retrograde axonal 
transport of acidic organelles in rodent DRGs [72]. Experiments in squid 
axoplasm suggest that Cdk5 regulates axonal transport indirectly via inhibition 
of GSK3β (see GSK3β section) [70]. Cdk5 has been shown to activate lemur 
tyrosine kinase-2 (LMTK2), which in turn phosphorylates and activates protein 
phosphatase 1 (PP1), thus preventing GSK3β activation [70, 73, 74]. Cdk5 
has also been described to regulate fast retrograde axonal transport through 
phosphorylation of the dynein adapter protein Ndel1. In rodent DRGs, 
phosphorylation of Ndel1 by Cdk5 increases its association with Lis1, leading 
to enhanced retrograde axonal transport of acidic organelles (Figure 2) [72]. 
 
However, a more recent study performed in rodent DRGs has failed to 
reproduce these results. In this study, expression of kinase-dead Cdk5 did not 
affect the axonal transport of lysosomes, mitochondria or TrkB-containing 
endosomes [75], suggesting that Cdk5 does not play a role in the regulation of 
axonal transport under normal conditions. By contrast, increasing Cdk5 
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activity disrupted the axonal transport of these cargoes [75] suggesting that 
Cdk5 modulates axonal transport only under cellular stress. Although the 
reason for these conflicting results is unclear, it may be related to differences 
in the protocol used for DRG isolation and maintenance [72, 75]. 
 
Cdk5 has also been shown to negatively regulate the slow anterograde 
axonal transport of neurofilaments [36, 46, 76, 77]. Phosphorylation of 
neurofilaments by Cdk5 is proposed to disrupt their anterograde axonal 
transport by promoting bundling [36, 78], reducing binding to kinesin [79] and 
inhibiting the activity of ERK1/2 through phosphorylation-mediated 
deactivation of its upstream activator MEK1 [46]. Cdk5 also disrupts the slow 
anterograde axonal transport of tau, although the mechanism responsible 
remains unclear [46]. 
 
Crucially, the level of crosstalk between different kinases known to 
phosphorylate neurofilament subunits remains to be addressed, together with 
the physiological implications of the resulting combinatorial phosphorylation 
patterns.  
 
Akt 
The serine/threonine kinase Akt (also known as protein kinase B) has been 
shown to regulate the directionality of fast axonal transport. Activation of Akt 
in rodent hippocampal neurons leads to the preferential anterograde axonal 
transport of BDNF-containing secretory vesicles, APP-containing vesicles and 
synaptic vesicles through phosphorylation of the adapter protein htt (Figure 1) 
[80]. Akt-mediated phosphorylation of htt at Ser421 increases the recruitment 
of kinesin-1 to vesicles and also increases the amount of kinesin heavy chain 
bound to microtubules [80]. Inhibition of Akt causes an increase in the rate of 
retrograde axonal transport of BDNF-containing vesicles (Figure 2) [80]. Akt 
can also inactivate GSK3β and thereby release the inhibitory effect of GSK3β 
on the fast axonal transport of mitochondria in hippocampal neurons [24, 81]. 
It will be interesting to determine whether these regulatory mechanisms are 
conserved across species and neuronal types. 
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Additional kinases implicated in the regulation of axonal transport  
There is a small body of evidence implicating other protein kinases in the 
regulation of axonal transport (Key Figure). In invertebrate models, both 
protein kinase A (PKA) and casein kinase 2 (CK2) inhibit fast anterograde 
axonal transport via direct phosphorylation of kinesin and reduction of its 
affinity for vesicular cargoes [19, 82]. In addition, CK2 has been shown to 
inhibit retrograde axonal transport via an unknown mechanism [82].  
 
However, these findings have not been confirmed in mammalian neurons. In 
contrast to its effects in an invertebrate model [19], PKA has been shown to 
facilitate the fast axonal transport of mitochondria in rodent DRGs [83]. It is 
unclear whether this reflects a difference in regulatory mechanisms between 
species or between different cargoes (mitochondria versus vesicular cargoes). 
 
Protein kinase C has been demonstrated to be a negative regulator of both 
retrograde [84] and anterograde [85] fast axonal transport, but further work is 
required to confirm the PKC isoform(s) responsible, their target(s) and the 
mechanism of action at the molecular level.  
 
Finally, overexpression of PTEN-induced putative kinase 1 (PINK1) has been 
shown to inhibit the bidirectional axonal transport of mitochondria through 
phosphorylation of the adapter protein Miro (Figure 1 and 2), which targets it 
for degradation [86].  
 
Relevance to CNS function and disease 
 
The regulation of axonal transport by protein kinases is essential for neuronal 
function and development. This mechanism has been shown to play an 
essential role in regulating axon integrity during pathfinding [87], establishing 
neuronal polarity [88] and regulating synaptic formation and maintenance [89]. 
Protein kinases also play a key role in the regulation of growth factor and 
stress signaling [90, 91] and the supply and clearance of proteins, lipids and 
organelles to the distal axon and synapse [27, 49, 80]. It is therefore not 
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surprising that the deregulation of axonal transport by protein kinases has 
been implicated in several nervous system disorders (Table 2). 
 
Amyotrophic lateral sclerosis (ALS)  
The early appearance of axonal transport deficits in ALS mouse models [13, 
92] suggests that they play a key role in disease pathogenesis. p38 MAPK is 
over-activated in spinal motor neurons of an ALS mouse model (SOD1G93A) 
[48, 93] and is responsible for defects in fast anterograde axonal transport 
induced by ALS-associated SOD1 mutants [48]. In addition, deregulation of 
p38 MAPK and Cdk5 is linked to the hyperphosphorylation of neurofilaments 
and subsequent disruption of their slow axonal transport observed in ALS [51, 
53, 93, 94].  
 
Huntington’s disease (HD) 
Mutant huntingtin (polyQ-htt) stimulates JNK3-mediated phosphorylation of 
KIF5C and induces deficits in both anterograde and retrograde axonal 
transport in squid axoplasm [56]. Interestingly, Akt-mediated phosphorylation 
of polyQ-htt at Ser421 can restore fast axonal transport to wild type levels 
[95]. 
 
Alzheimer’s disease (AD)  
 Aβ is proposed to inhibit fast axonal transport through Akt inhibition [96] and 
activation of CK2 [82], GSK3β [29, 96, 97] and p38 MAPK [49]. AD-
associated presenilin 1 mutations and hyperphosphorylated tau have also 
been shown to induce axonal transport defects through activation of GSK3β 
[25, 96, 98]. Correcting fast axonal transport defects by reducing GSK3β 
activity was found to be beneficial in AD models [99, 100]. Deregulation of 
Cdk5 is also linked to defects in the slow axonal transport of neurofilaments in 
AD [77]. 
 
Spinal bulbar muscular atrophy (SBMA)  
SBMA is caused by a CAG repeat expansion in the first exon of the androgen 
receptor (polyQ-AR). Perfusion of the polyQ-AR in squid axoplasm inhibits the 
fast axonal transport of membrane-bound organelles through stimulation of 
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JNK3-mediated phosphorylation of the kinesin heavy chain [55]. However, the 
role of axonal transport deficits in SBMA is controversial, since alterations in 
axonal transport were not found in vivo in a mouse model of SBMA 
expressing endogenous levels of polyQ-AR [101]. 
 
Charcot-Marie-Tooth type 2F (CMT2F)  
CMT2F-mutant HSPB1 has been shown to induce alterations in the slow 
anterograde axonal transport of neurofilaments [79]. Mutant HSPB1 activates 
Cdk5, leading to neurofilament bundling and reduced association with kinesin-
1.  
 
Over-activation of protein kinases and the subsequent disruption of axonal 
transport are a common occurrence in neurodegenerative diseases [102]. 
However, the direct demonstration that kinase-induced disruptions in axonal 
transport trigger disease pathogenesis is still lacking. The identification of 
pharmacological inhibitors of key protein kinases, such as GSK3β, JNK3 and 
p38 MAPK, able to restore their activity to basal levels and normalize axonal 
transport, will help answer this question and determine whether protein 
kinases represent effective therapeutic targets for neurodegenerative 
diseases. 
 
Concluding remarks and future perspectives 
 
The complex scenario emerging from these studies highlights the crucial role 
played by protein kinases in the modulation of axonal transport. Motors, 
adapters and cargoes are clearly key targets for differential regulation by 
phosphorylation; something we are only just beginning to understand. Many 
intriguing questions still remain to be answered (see Outstanding Questions 
Box). 
 
Given the key role that axonal transport plays in neuronal function, it is not 
surprising that alterations in protein kinase activity disrupt the axonal transport 
of selected cargoes and may lead to the severe pathological features of many 
nervous system disorders. Protein kinases may therefore represent key 
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therapeutic targets for several neurological diseases that currently lack 
effective therapies. However, targeting protein kinases in neurological 
diseases presents a number of challenges [103]. In particular, there are likely 
to be problems with off-target effects, as protein kinases are often involved in 
the regulation of many cellular processes and participate in multiple signaling 
pathways. Understanding how to control the phosphorylation of specific 
substrates will aid the design of novel kinase inhibitors with fewer off-target 
effects. 
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Box 1. The structure of kinesin-1 and dynein/dynactin motor complexes  
 
Kinesin-1. Structural studies have revealed that kinesin-1 is a rod-shaped 
protein, with globular heads connected by a stalk to a tail domain. The 
carboxy terminal domains of the two KIF5 subunits associate with two KLCs 
and mediate cargo binding. The amino terminal globular heads of KIF5 form 
the motor domains and contain ATP and microtubule binding sites. Kinesin-1 
is able to take steps along the microtubule by alternately detaching and 
advancing each of its two globular heads [104]. High-resolution X-ray 
crystallography and cryo-EM microscopy of kinesin-1 in complex with tubulin 
in both ATP-bound and nucleotide-free states have provided insights into how 
the motor moves [104]. ATP binding to the “front” motor domain not only 
allows high affinity binding to microtubules, but also triggers conformational 
changes in the “rear” globular head that allows it to detach from microtubules 
and take a step. Steps are driven by conversion of the neck linker domain 
from a disordered state to a well-defined structure. 
 
Cytoplasmic dynein/dynactin. Dynein is composed of two heavy chains 
(DHCs) and additional intermediate (DICs), light intermediate (DLICs) and 
light chains (DLCs). The carboxy terminal region of DHC consists of a ring of 
six putative AAA+ ATPase domains (AAA1-6). ATP binding to AAA1 lowers 
the affinity of the microtubule-binding domain for microtubules so that the 
DHC can detach and diffuse to its next binding site. ATP hydrolysis induces 
remodeling of the linker domain and allows the motor to complete the step 
[105]. The amino terminus of the DHC mediates dimerization and binding to 
DICs, DLICs and DLCs to form the cargo-binding domain. DICs contain the 
dynactin-binding region. Dynactin consists of eight core subunits: p150Glued, 
dynamitin/p50, Arp1, Arp11, p62, p24, p25 and p27 [106]. A dimer of p150Glued 
forms a bridge between the dynein intermediate chain and microtubules that 
is believed to increase motor processivity. Dynamitin/p50 overexpression 
inhibits dynein-mediated axonal transport by causing the release of p150Glued 
and p24, thus disrupting the dynein-dynactin complex [107]. BICD2 is required 
to stabilize the interaction between dynein and dynactin, allowing the 
processive movement of the complex [108].  
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Glossary 
 
Cargo: Organelles, vesicles, RNA or proteins that are carried by molecular 
motor complexes along microtubules. 
 
Microtubules: polymers of tubulin that extend throughout axons and 
dendrites and form the tracks along which molecular motors move. 
Microtubules are polarized in axons, conferring directionality to axonal 
transport.  
 
Neurofilaments: a type of intermediate filament found specifically in neurons. 
Neurofilaments are composed of three major subunits: light (NF-L), medium 
(NF-M) and heavy (NF-H). They are thought to provide structural support for 
axons, regulate axon diameter and act as a scaffold for various axonal 
components. 
 
Protein kinase: an ATP-dependent enzyme (phosphotransferase) that adds 
a phosphate group to its protein substrate. Phosphorylation typically causes a 
functional change in the substrate, such as altering its activity, cellular location 
or association with other proteins. 
 
Squid axoplasm: extruded cytoplasm of the giant axons of the squid Loligo 
pealeii. Differential interference contrast (DIC) microscopy is used to observe 
the bidirectional movement of membrane-bound organelles in real time. 
Axoplasm can be perfused with recombinant proteins and small molecular 
inhibitors in order to determine their effects on axonal transport. 
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Figure legends 
 
Figure 1. Cargo-specific regulation of anterograde axonal transport by 
protein kinases. 
Examples of cargoes whose anterograde axonal transport is regulated by 
phosphorylation. Protein kinases that have been shown to regulate the 
anterograde transport of specific cargoes are listed. Their molecular targets 
are indicated in parentheses. For many of the molecular targets, the 
phosphorylation site(s) have been identified (see Table 1). Question marks 
indicate that contradicting results have been reported on the effect of the 
specific protein kinase on axonal transport.  
 
Figure 2. Cargo-specific regulation of retrograde axonal transport by 
protein kinases. 
Examples of cargoes whose retrograde axonal transport is regulated by 
phosphorylation. Protein kinases that have been shown to regulate the 
retrograde transport of specific cargoes are listed, together with their 
molecular targets, if known. For many of the molecular targets, the 
phosphorylation site(s) have been identified (see Table 1). 
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Table 1. Protein kinases that directly regulate axonal transport a  
 
Kinase Target Cargo affected 
Effect on AT 
Type of neuron Ref 
aAT rAT 
GSK3β 
  
  
KLC2 Membrane-bound organelles - - Squid axoplasm [23, 26] 
DIC1B (Ser87/Thr88); DIC2C (Ser88/Thr89) Acidic organelles NE - Dorsal root ganglia [28] 
? 
Mitochondria, APP-containing vesicles,  
lipid droplets, synaptic vesicles (?),  
BDNF-containing secretory vesicles 
- - 
Hippocampal neurons,  
Drosophila segmental nerves  
[24, 25, 27, 29] 
Tau Tau +  Cortical neurons [35] 
NF-H Neurofilaments -  NB2a/d1 cells [36] 
ERK1/2 
  
  
DIC1B (Ser80); DIC2C (Ser81) Signaling endosomes 
 
+ Hippocampal neurons [42] 
KLC1 (Ser460) Calsyntenin-associated vesicles (APP) - + Cortical neurons [41] 
GSK3β (Ser9) Neurofilaments +  NB2a/d1 cells, dorsal root ganglia [36] 
p38 MAPK 
  
KIF5C (Ser175/176) Membrane-bound organelles - NE Squid axoplasm [48] 
? Mitochondria - - Hippocampal neurons [49] 
? Synaptic vesicles -  Drosophila segmental nerves [50] 
NF-M and -H Neurofilaments -  Cortical neurons [51, 53] 
JNK 
  
  
  
JIP1 (Ser421) APP-containing vesicles + - Dorsal root ganglia [60] 
KIF5C (Ser176) Membrane-bound organelles - - Squid axoplasm [55, 56] 
KIF5B Mitochondria, synaptic vesicles - - Hippocampal neurons [55-57] 
? Neurofilaments -  NB2a/d1 cells, dorsal root ganglia [64] 
Cdk5  
  
  
LMTK2/PP1 Membrane-bound organelles + + Squid axoplasm, dorsal root ganglia [70, 109] 
? Synaptic vesicles +  C.elegans motor neurons [110] 
Ndel1 Acidic organelles  + + Dorsal root ganglia [72] 
MEK  Neurofilaments -  NB2a/d1 cells [46] 
NF-M and -H Neurofilaments -  Dorsal root ganglia, SH-SY5Y [36, 76, 77, 79] 
Akt 
  
htt (Ser421) 
BDNF-containing secretory vesicles,  
APP-containing vesicles, synaptic vesicles + - Cortical neurons [80] 
GSK3β (Ser9) Mitochondria + + Hippocampal neurons [24, 81] 
PKA 
  
Kinesin Small vesicles (not mitochondria) - NE Crayfish walking leg giant axon [19] 
? Mitochondria + + Dorsal root ganglia [83] 
CK2 KLC1 and 2 Membrane-bound organelles - - Squid axoplasm [82] 
PKC ? Membrane-bound organelles - - 
Sympathetic and sensory neurons, 
squid axoplasm 
[84, 85] 
PINK1 Miro (Ser156) Mitochondria - - Cortical neurons [86] 
 
a. rAT, retrograde axonal transport. aAT, anterograde axonal transport. +, enhanced; -, inhibited; NE, no effect. 
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Table 2. Protein kinases implicated in the deregulation of axonal transport in neurological diseases a 
 
Kinase Target Cargo affected 
Effect on AT 
Type of neuron Disease association Ref 
aAT rAT 
p38 MAPK 
 
KIF5C (Ser175/176) Membrane-bound organelles - NE Squid axoplasm Amyotrophic lateral sclerosis [48] 
? Signalling endosomes (CTB) -  Optic nerve Glaucoma  [111] 
? Mitochondria - - Hippocampal neurons Alzheimer’s disease [49] 
NF-M and -H Neurofilaments -  Cortical and motor neurons Amyotrophic lateral sclerosis [51, 53, 93] 
Cdk5 NF-M and -H Neurofilaments -  SH-SY5Y, N2A 
Charcot-Marie-Tooth type 2F, 
Alzheimer’s disease 
[36, 76, 77, 79] 
CK2 KLC1 and 2 Membrane-bound organelles - - Squid axoplasm Alzheimer’s disease [82] 
GSK3β 
 ? 
Synaptic vesicles, mitochondria, 
APP-containing vesicles, BDNF-
containing secretory vesicles 
- - 
Hippocampal neurons, Drosophila 
segmental nerves, squid axoplasm 
Alzheimer’s disease 
[23, 25, 27, 29, 
96-98] 
KLC Mitochondria - - Cortical neurons Krabbe disease [23] 
JNK3 
 
KIF5C (Ser176) Membrane-bound organelles - - Squid axoplasm Huntington’s disease  [56] 
KIF5 Membrane-bound organelles - - Squid axoplasm 
Spinal bulbar muscular 
atrophy 
[55] 
PKC ? Membrane-bound organelles - NE Squid axoplasm 
Neurotoxin-induced 
Parkinson’s disease  
[85] 
 
a. rAT, retrograde axonal transport. aAT, anterograde axonal transport. +, enhanced; -, inhibited; NE, no effect. 
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Outstanding Questions 
 
 Do kinases other than ERK1/2 and GSK3β directly phosphorylate 
cytoplasmic dynein? What effects does this process have on axonal 
transport? 
 Do protein kinases phosphorylate the dynactin complex and, if so, how 
does this affect the activity and processivity of the dynein motor? 
 Are kinesin-2 and -3 regulated by direct phosphorylation as seen for 
kinesin-1? 
 Is the axonal transport of RNA also regulated by protein kinases? 
Which aspects of the regulatory network are shared between the 
different classes of organelles and how is specificity achieved? 
 What are the molecular mechanisms underlying the deregulation of 
protein kinases in neurodegenerative diseases and how is axonal 
transport affected? 
 Can we specifically target protein kinases and axonal transport as a 
therapeutic strategy for neurodegenerative diseases and other 
disorders of the nervous system? 
Outstanding Questions
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